Search Results 2831-2840 of 16712 for pneumococcal vaccination

  1. Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma - Mayo Clinic

    Live vaccine within 30 days prior to day 1 of protocol therapy (e.g. measles ... vaccine, and oral typhoid). Refractory to prior brentuximab vedotin ...

  2. Children's health

    Videos. Mayo Clinic Minute: Why and when children should be vaccinated ... Mayo Clinic Minute: Why getting vaccinated for the flu is doubly important this season.

  3. Publications - Michael R. Mueller, M.D. - Mayo Clinic

    ... vaccination. J Investig Med. 2023 Dec; 71 (8):889-895 Epub 2023 Aug 23. View PubMed; Thilagar BP, Mueller MR, Ganesh R. Perioperative cardiac risk reduction ...

  4. Publications - Michael J. Joyner, M.D. - Mayo Clinic

    Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19. ... Plasma after both SARS-CoV-2 ...

  5. Neutropenia (low neutrophil count) - Mayo Clinic

    All white blood cells help the body fight infections. But neutrophils are important for fighting certain infections, especially those caused by bacteria. If you ...

  6. Publications - Josh P. Wiedermann, M.D. - Mayo Clinic

    Feasibility of Instituting a Clinical Otolaryngology Human Papillomavirus (HPV) Vaccination Program. Laryngoscope. 2023 Jan; 133 (1):116-123 Epub 2022 Apr ...

  7. Publications - Martin L. Mai, M.D. - Mayo Clinic

    ... Vaccination. Clin Transplant. 2025 Jan; 39 (1):e70071. View PubMed; Heilman RL, Fleming JN, Mai M, Smith B, Park WD, Holman J, Stegall MD. Multiple abnormal ...

  8. Heart attack - Doctors and departments - Mayo Clinic

    Atrial fibrillation, COPD, Heart attack, Pneumonia, Chest pain ... Calcium supplements: A risk factor for heart attack? Flu Shot Prevents Heart Attack ...

  9. Crohn's Disease Clinical Trials

    The purpose of this study is to assess the effect of vedolizumab subcutaneous (vedolizumab SC) as maintenance treatment in participants with moderately to ...

  10. Publications - Kristen B. McCullough, Pharm.D., R.Ph. - Mayo Clinic

    Busulfan Treatment for Myeloproliferative Disease may Reduce Injection Burden in Vascular Endothelial Growth Factor-Driven Retinopathy. Am J Ophthalmol Case ...